Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02181 MABPHARM-B
RT Nominal down0.450 -0.025 (-5.263%)
Latest  |  Final  |  Interim
Non-current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/06
RMB(K¥)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others485,010-5.091%532,623590,824621,689596,266
Land & other Lease Assets56,706-2.179%59,84466,68463,53372,809
Intangible Assets139,80045.238%61,697000
Interests in Asso. & JCEs0--0000
Other Non-current Assets65,31421.152%3,3845,8167,53544,700

746,8303.848%657,548663,324692,757713,775
Current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/06
RMB(K¥)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
Inventories145,0146.188%145,782101,703103,23780,358
Trade Receivables150,468-2.961%145,33564,15129,0103,850
Cash & Bank Balances93,328-14.580%94,16274,06623,14280,286
Other Current Assets32,982-1.308%25,01943,15054,80359,735
Assets Held for Sale0--0000

421,792-2.880%410,298283,070210,192224,229
Current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/06
RMB(K¥)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
Trade Payables41,20236.580%29,23512,24616,35728,874
S-T Debt & Leases157,541-32.596%110,14248,07263,79013,390
Other Current Liabilities304,84612.843%243,631204,994173,717180,757
Liab asso w/ Assets Held for Sale0--0000

503,589-5.703%383,008265,312253,864223,021
Net Current Assets(81,797)-17.993%27,29017,758(43,672)1,208
Total Assets Less Current Liabilities665,0337.365%684,838681,082649,085714,983
Non-current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/06
RMB(K¥)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
L-T Debt & Leases150,39561.692%194,868195,56083,682113,295
Other Non-current Liabilities320,801-13.085%391,107370,331258,780110,560

471,1961.966%585,975565,891342,462223,855
Capital and Reserves
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/06
RMB(K¥)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
  Share Capital2,8040.000%2,8042,8042,8042,804
  Reserves191,03323.646%96,059112,387303,819488,324
  Others0--0000
Shareholders' Funds193,83723.224%98,863115,191306,623491,128
Non-controlling Interests0--0000
Others0--0000

193,83723.224%98,863115,191306,623491,128
Commitments and Contingent Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/06
RMB(K¥)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
Commitments------------
Contingent Liabilities------------
Remarks:  Real time quote last updated: 10/09/2026 17:11
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 31,360
%Change982.126%
EPS / (LPS)RMB 0.010
NBV Per Share (¥)RMB 0.047
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.